ETHIOPIA – A crucial public health decision looms in May 2025 as Africa’s top health experts prepare to assess whether mpox (monkeypox) should remain classified as a public health emergency of continental concern. The review comes amid a complex epidemiological picture, with some countries reporting rising infections while others show signs of progress. Africa CDC […]
ETHIOPIA – The Africa Centres for Disease Control and Prevention (Africa CDC) has applauded Uganda for officially ending its eighth outbreak of Sudan Ebola Virus Disease (SVD). The milestone marks a significant public health achievement following 42 days with no new infections since the last confirmed case on 2 March 2025. The final patient was […]
USA – Vivo Capital has raised US $740 million to support early-stage biotech and life science companies, marking a bold move during a slowdown in venture capital funding for the sector. The money will be used in the latest cycle of the Vivo Opportunity Fund, an evergreen investment vehicle that operates in three-year rounds. Unlike […]
SWITZERLAND – Haya Therapeutics has raised US $65 million in a Series A funding round to accelerate the clinical development of its experimental heart failure drug, HTX-001. The funding will also support the expansion of Haya’s proprietary RNA-guided drug discovery platform, which targets the “dark genome,” the 98% of human DNA that doesn’t code for […]
USA – Eli Lilly has entered into a licensing agreement worth up to US $415 million with UK-based biotech Alchemab Therapeutics for ATLX-1282. The therapy is an experimental antibody treatment aimed at slowing the progression of amyotrophic lateral sclerosis (ALS) and potentially other neurodegenerative diseases. The agreement includes an undisclosed upfront payment, milestone-based rewards tied […]
KENYA – Kenya has taken a major step in strengthening its health system with the official launch of the Kenya National Public Health Institute (KNPHI). Unveiled by Health Cabinet Secretary Aden Duale at the Kenyatta International Convention Centre, the new institute is set to play a central role in improving disease prevention and strengthening the […]
USA — Novavax has reported a major jump in revenue, even as uncertainty lingers over the full approval of its updated COVID-19 vaccine. In its Q1 2025 earnings call, the Maryland-based biotech announced US $667 million in total revenue, marking a 610% increase from the US $94 million reported in the same quarter last year. […]
JAPAN – Takeda is making a bold commitment to its future in the U.S., announcing plans to invest approximately US $30 billion in its American operations over the next five years. Speaking during the company’s full-year 2024 earnings call, CEO Christophe Weber emphasized that this move reflects the importance of the U.S. as a global […]
USA – Kenvue exceeded quarterly profit and revenue expectations, driven by strong demand for its self-care products, including cough-and-cold brands like Tylenol and Benadryl. Despite weaker performance in its skin-health and beauty segment, shares rose nearly 5% in premarket trading. The consumer health company, which spun off from Johnson & Johnson in 2023, reported first-quarter […]
CANADA – The World Ovarian Cancer Coalition has launched a major new effort to make ovarian cancer a top global health priority on World Ovarian Cancer Day (#WOCD2025). The coalition announced the creation of the Global Expert Advisory Group on Ovarian Cancer, an international team of advocates, doctors, and policymakers from 13 countries across six […]
KENYA – Kenya is set to benefit from a new US $600 million initiative aimed at reducing maternal and newborn deaths across Africa. Launched last week by a coalition of global philanthropies, the Beginnings Fund will support up to ten African countries, including Kenya, Ethiopia, Ghana, Malawi, Lesotho, Nigeria, Rwanda, Tanzania, Uganda, and Zimbabwe – […]
JAPAN – Shionogi is making a major move to grow its drug pipeline and reach its long-term goals by acquiring Japan Tobacco’s pharmaceutical operations. In a deal announced Wednesday, the Japanese drugmaker will pay over 150 billion yen (US $1.05 billion) to take over Torii Pharmaceutical and Japan Tobacco’s pharma businesses, including its U.S. subsidiary […]
XRP HEALTHCARE L.L.C | License Number: 2312867.01 | Dubai | © Copyright 2025 | All Rights Reserved